BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Docket Clock//docket-clock.pages.dev//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharmacokinetics in Patients With Impaired Hepatic Function:
X-PUBLISHED-TTL:PT12H
REFRESH-INTERVAL;VALUE=DURATION:PT12H
BEGIN:VEVENT
UID:2026-17961-close@docket-clock.pages.dev
DTSTAMP:20261017T145145Z
DTSTART;VALUE=DATE:20261201
DTEND;VALUE=DATE:20261202
SUMMARY:FDA comments close: Pharmacokinetics in Patients With Impaired Hep
 atic Function: Study Design\, Data Analysis\, and Impact on Dosage\; Draf
 t Guidance for Industry\; Availability
DESCRIPTION:Notice. Federal Register 2026-17961. Docket FDA-2026-D-8693. D
 etails: https://docket-clock.pages.dev/doc/2026-17961/ Official: https://
 www.federalregister.gov/documents/2026/09/02/2026-17961/pharmacokinetics-
 in-patients-with-impaired-hepatic-function-study-design-data-analysis-and
 -impact-on
URL:https://www.federalregister.gov/documents/2026/09/02/2026-17961/pharma
 cokinetics-in-patients-with-impaired-hepatic-function-study-design-data-a
 nalysis-and-impact-on
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR